American depositary receipts of European stocks were trading 0.43% higher at 120.25 on the Bank of New York Mellon Europe ADR Index on Tuesday.
In continental Europe, the gainers were led by 3D printer company Materialise ( MTLS ) and pharmaceutical firm Oasmia Pharmaceutical ( OASM ), which surged 10.8% and 7.3% respectively. They were followed in part by semiconductor company STMicroelectronics ( STM ), which was up 3.8%.
The decliners in continental Europe were led by furniture maker Natuzzi ( NTZ ) and internet browser company Opera ( OPRA ), which fell 4.7% and 1.6% respectively. They were followed by Spanish telecommunications operator Telefonica (TEF) and health care company Novo Nordisk (NVO), which were off 1% and 0.5%.
In the UK and Ireland, the gainers were led by biopharmaceutical firm NuCana (NCNA) and airplane leasing company Fly Leasing (FLY), which rose 4% and 3.7% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and pharmaceutical company Avadel (AVDL), which were up 2.7% and 2.2%.
The decliners in the UK and Ireland were led by biopharmaceutical company Verona Pharma (VRNA) and natural gas distributor National Grid (NGG), which fell 10.7% and 6.1% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and biotech company Shire (SHPG), which shed 5.7% and 2%.
European ADRs Move Higher in Tuesday Trading
Shutterstock photo
American depositary receipts of European stocks were trading 0.43% higher at 120.25 on the Bank of New York Mellon Europe ADR Index on Tuesday.
In continental Europe, the gainers were led by 3D printer company Materialise ( MTLS ) and pharmaceutical firm Oasmia Pharmaceutical ( OASM ), which surged 10.8% and 7.3% respectively. They were followed in part by semiconductor company STMicroelectronics ( STM ), which was up 3.8%.
The decliners in continental Europe were led by furniture maker Natuzzi ( NTZ ) and internet browser company Opera ( OPRA ), which fell 4.7% and 1.6% respectively. They were followed by Spanish telecommunications operator Telefonica (TEF) and health care company Novo Nordisk (NVO), which were off 1% and 0.5%.
In the UK and Ireland, the gainers were led by biopharmaceutical firm NuCana (NCNA) and airplane leasing company Fly Leasing (FLY), which rose 4% and 3.7% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and pharmaceutical company Avadel (AVDL), which were up 2.7% and 2.2%.
The decliners in the UK and Ireland were led by biopharmaceutical company Verona Pharma (VRNA) and natural gas distributor National Grid (NGG), which fell 10.7% and 6.1% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and biotech company Shire (SHPG), which shed 5.7% and 2%.
HealthEquity Ends 2018 Strong, but Predicts a Slowdown Ahead
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.